SENS
NASDAQ HealthcareSenseonics Holdings, Inc. - Common Stock
Medical Devices
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
๐ Market Data
| Price | $8.03 |
|---|---|
| Volume | 595,962 |
| Market Cap | 424.58M |
| Beta | 0.970 |
| RSI (14-Day) | 85.3 Overbought |
| 200-Day MA | $6.46 |
| 50-Day MA | $5.98 |
| 52-Week High | $11.58 |
| 52-Week Low | $4.79 |
| Forward P/E | -4.12 |
| Price / Book | 4.70 |
๐ฏ Investment Strategy Scores
SENS scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ Over-Hyped (98/100) โ this strategy Overbought stocks (potential short candidates).
Lowest fit among scored strategies: ๐ช Falling Knife (6/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find SENS in your text
Paste any article, transcript, or post โ the tool will extract SENS and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-08-17.